The stock may react negatively to the 2026 EBITDA guidance being below 2025 levels despite strong full-year 2025 performance, but the significant cash flow improvement and cost savings program could provide some support. Monitor the company's ability to execute on its IMPACT program and navigate industry headwinds.
Price Chart
Executive Summary
Ardent Health reported mixed Q4 2025 results with flat revenue and a 61% YoY decline in net income, but strong full-year 2025 growth of 6% in revenue and 9.3% in Adjusted EBITDA. The company issued conservative 2026 guidance with Adjusted EBITDA expected to decline to $485-$535 million, citing ongoing industry headwinds, while highlighting $55 million in expected cost savings from its IMPACT program.
Key Financial Metrics
Key Facts
- Q4 2025 revenue flat YoY at $1.605 billion, but net income fell 61% YoY to $45 million
- Full-year 2025 revenue grew 6.0% to $6.32 billion and Adjusted EBITDA grew 9.3% to $545 million
- 2026 guidance: Adjusted EBITDA of $485-$535 million, a decline from 2025's $545 million
- Company generated $471 million in operating cash flow for 2025, up 49% YoY
- IMPACT cost savings program expected to generate $55 million in 2026, up from $40 million in 2025
Financial Impact
Revenue flat in Q4, but full-year 2025 revenue up 6.0% to $6.32 billion; Adjusted EBITDA down 26.6% in Q4 but up 9.3% for full-year 2025; 2026 Adjusted EBITDA guidance down to $485-$535 million
Risk Factors
- 2026 Adjusted EBITDA guidance is below 2025 levels, indicating ongoing profitability pressure
- Q4 net income declined 61% YoY, raising concerns about near-term earnings
- Company cited 'annualization of elevated professional fees and other rate pressures driven by payor denials' as headwinds
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-014640 |
| Document: ardt-20260304.htm | 0001628280-26-014640 |
| Document: 0001628280-26-014640-index-headers.html | 0001628280-26-014640 |
| Document: 0001628280-26-014640-index.html | 0001628280-26-014640 |
| Document: 0001628280-26-014640.txt | 0001628280-26-014640 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $12.27 | awaiting T+20 | — | $11.78 (+3.95%) |
Aug 20, 2026 9w ago | 144 | $10.99 $10.61 | ▼ −3.46% | ▼ −2.93% | $11.78 (+7.23%) |
Aug 15, 2026 10w ago | Institutional Cluster | $10.89 $10.69 | ▼ −1.84% | ▲ +0.14% | $11.78 (+8.22%) |
Jun 30, 2026 16w ago | 8-K | $10.13 $10.93 | ▲ +7.90% | ▲ +10.08% | $11.78 (+16.34%) |
Jun 11, 2026 19w ago | Institutional Cluster | $9.67 $10.09 | ▲ +4.34% | ▲ +2.45% | $11.78 (+21.87%) |
Jun 2, 2026 20w ago | 8-K | $7.83 $10.76 | ▲ +37.42% | ▲ +38.42% | $11.78 (+50.51%) |
May 5, 2026 24w ago | 8-K | $9.37 $7.83 | ▼ −16.44% | ▼ −19.22% | $11.78 (+25.77%) |
Apr 8, 2026 28w ago | DEFA14A | $9.53 $9.37 | ▼ −1.68% | ▼ −9.25% | $11.78 (+23.66%) |
Mar 4, 2026 33w ago | 8-K | $9.44 $8.66 | ▼ −8.26% | ▼ −4.47% | $11.78 (+24.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers